Lawsuits filed in New Jersey are part of hundreds of complaints against UnitedHealthcare, PBMs, and pharmaceutical giants ...

The proposed buyout of contract drug manufacturer Catalent won’t raise competition concerns, the European Commission said.

Few companies have broken into the public’s consciousness as thoroughly as Novo Nordisk has over the past ... took steps to minimize demand from new patients and increase the likelihood there ...

Catalent is a global contract development and manufacturing organisation headquartered in New Jersey (US). The parties are now free to close the transaction, as well as Novo Nordisk’s subsequent ...